| Literature DB >> 14680434 |
Alan Ronald Bremner1, David Mervyn Griffiths, Robert Mark Beattie.
Abstract
Ulcerative colitis presents in childhood in 10% of those affected, usually with pancolitis. Important features in management include growth, development and avoidance of treatment toxicity. This review addresses the current treatment options including both the paediatric evidence-based experience and areas where paediatric practice is informed by adult studies. Standard treatments include sulfasalazine or 5-aminosalicylates, corticosteroids, purine derivatives (azathioprine or 6-mercaptopurine) and surgery. Other immunosuppressant therapies and the emerging roles for biological therapies and probiotics are discussed.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14680434 DOI: 10.1517/14656566.5.1.37
Source DB: PubMed Journal: Expert Opin Pharmacother ISSN: 1465-6566 Impact factor: 3.889